IFIT3 and HIV-1 infection: The upregulation of IFIT3 in response to HIV-1 infection and subsequent reduction after cART treatment demonstrated the ability of cART to normalize immune function and reduce chronic immune activation, a key factor in HIV-associated neuroinflammation.